| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |